vTv Therapeutics Inc. (NASDAQ: VTVT)
$23.70
+1.1900 ( +5.29% ) 20.1K
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Market Data
Open
$23.70
Previous close
$22.51
Volume
20.1K
Market cap
$57.78M
Day range
$22.97 - $24.67
52 week range
$7.38 - $31.20
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Dec 19, 2023 |
| 8-k | 8K-related | 12 | Dec 12, 2023 |
| 8-k | 8K-related | 12 | Nov 20, 2023 |
| 8-k | 8K-related | 30 | Nov 15, 2023 |
| 8-k | 8K-related | 12 | Nov 15, 2023 |
| 8-k | 8K-related | 14 | Nov 09, 2023 |
| 10-q | Quarterly Reports | 70 | Nov 09, 2023 |
| 8-k | 8K-related | 14 | Nov 01, 2023 |
| def | Proxies and info statements | 2 | Sep 25, 2023 |
| pre | Proxies and info statements | 2 | Sep 15, 2023 |